IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients (2017)
- Autores:
- Autor USP: TRAINA, FABÍOLA - FMRP
- Unidade: FMRP
- DOI: 10.1186/s41241-017-0017-9
- Assuntos: LEUCEMIA MIELOIDE; IMUNOLOGIA; INTERLEUCINAS; CITOCINAS
- Palavras-chave do autor: IL-32; Myelodysplastic syndromes; Disease progression; CD3+ cells; Immunology
- Agências de fomento:
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Applied Cancer Research
- ISSN: 1980-5578
- Volume/Número/Paginação/Ano: v. 37, art. 9, 6 p., 2017
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by
-
ABNT
LOPES, Matheus Rodrigues et al. IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients. Applied Cancer Research, v. 37, p. 6 , 2017Tradução . . Disponível em: https://doi.org/10.1186/s41241-017-0017-9. Acesso em: 18 set. 2024. -
APA
Lopes, M. R., Pereira, J. K. N., Traina, F., Campos, P. de M., Machado Neto, J. A., Saad, S. T. O., & Favaro, P. (2017). IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients. Applied Cancer Research, 37, 6 . doi:10.1186/s41241-017-0017-9 -
NLM
Lopes MR, Pereira JKN, Traina F, Campos P de M, Machado Neto JA, Saad STO, Favaro P. IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients [Internet]. Applied Cancer Research. 2017 ; 37 6 .[citado 2024 set. 18 ] Available from: https://doi.org/10.1186/s41241-017-0017-9 -
Vancouver
Lopes MR, Pereira JKN, Traina F, Campos P de M, Machado Neto JA, Saad STO, Favaro P. IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients [Internet]. Applied Cancer Research. 2017 ; 37 6 .[citado 2024 set. 18 ] Available from: https://doi.org/10.1186/s41241-017-0017-9 - FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation
- Increased inflammatory markers and their correlations to clinical complications in hemoglobin SC disease
- YAP1 expression in myelodysplastic syndromes and acute leukemias. [Carta]
- ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells
- Differential profile of PIP4K2A expression in hematological malignancies
- Abnormal Hedgehog pathway in myelodysplastic syndrome and its impact on patients' outcome. [Carta]
- Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea
- IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms
- Padronização da investigação laboratorial de anticorpos dirigidos contra fármacos em doadores de sangue e pacientes com anemia hemolítica imune
- Hedgehog pathway is deregulated in myelodysplastic syndrome progenitor bone marrow cells
Informações sobre o DOI: 10.1186/s41241-017-0017-9 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
